BXL-083

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBXL-083
Drug Alias Namevitamin D3 analogs (BioXell/ProStrakan)VD3 analogs (2HPT) (BioXell/Prostrakan)BXL-083
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D receptor agonistsVitamin D analogues
TargetsVitamin D receptor
Therapy Area/IndicationsHyperparathyroidism, Secondary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioxell SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProSkelia Pharmaceuticals SASBioxell SPAGalapagos Nv
Active IndicationsN/A
Inactive IndicationsHyperparathyroidism, Secondary

Other Information

ATC CodeN/A
Related LinksN/A